Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix and Caliper to Develop Automated Target Preparation Instrument

NEW YORK, Jan. 13 (GenomeWeb News) - Affymetrix and Caliper Technologies plan to co-develop automated target preparation instruments for Affy's microarray platforms, the companies said today.

 

The first instruments developed under the multi-year agreement are scheduled to come out later this year. Affymetrix, of Santa Clara, Calif., will market and distribute the systems, which Caliper will provide under an OEM agreement. Caliper, located in Hopkinton, Mass., will be responsible for installation, training, and repair.

 

Separately, Caliper Technologies said it will change its name to Caliper Life Sciences, effective Jan. 23.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.